QIU Jiagao, GU Xuewen, WANG Cuimei. Clinicopathological study of 7 cases with mixed neuroendocrine-non-neuroendocrine neoplasms[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 43-46. DOI: 10.7619/jcmp.20210764
Citation: QIU Jiagao, GU Xuewen, WANG Cuimei. Clinicopathological study of 7 cases with mixed neuroendocrine-non-neuroendocrine neoplasms[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 43-46. DOI: 10.7619/jcmp.20210764

Clinicopathological study of 7 cases with mixed neuroendocrine-non-neuroendocrine neoplasms

More Information
  • Received Date: February 23, 2021
  • Available Online: June 14, 2021
  • Published Date: June 14, 2021
  •   Objective  To study the clinicopathologic features of mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN).
      Methods  The medical records of 7 MiNEN cases were collected. The histopathological morphology was observed, the histopathological and immunohistochemical were labeled, and the clinicopathologic features and prognosis were analyzed.
      Results  Among 7 cases, there were 5 males and 2 females, aged 48 to 83 years. The neoplasm of 1 case located in esophagus, 3 in stomach, 1 in duodenum, 1 in rectum, and 1 in pancreas. Microscopy showed that the tumor of esophagus was squamous cell carcinoma and neuroendocrine tumor(NET G3). Non-neuroendocrine tumors of stomach, duodenum, rectum were adenocarcinoma, and their neuroendocrine tumors were small cell carcinoma (3 cases), large cell carcinoma (1 case), and NET G3 (1 case), and tumors of pancreas showed it belonged to ductal carcinoma and neuroendocrine tumor(NET G1). Non-neuroendocrine tumors (squamous cell carcinoma or adenocarcinoma) showed positive epithelium by immunohistochemical staining; there were 7 cases with positive CKpan and Syn of neuroendocrine tumor, 6 cases of positive CD56 and 1 case of negative CD56. The percentage of patients with positive Ki67 protein was 1%to 80%. Three of seven cases had lymph node metastasis. The follow up lasted for 3 to 33 months. During follow-up, 5 patients were alive and 2 died.
      Conclusion  MiNEN is an uncommon neoplasm. Correct diagnosis is important for clinical treatment and prognosis.
  • [1]
    FRIZZIERO M, WANG X, CHAKRABARTY B, et al. Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres[J]. World J Gastroenterol, 2019, 25(39): 5991-6005. doi: 10.3748/wjg.v25.i39.5991
    [2]
    MENDOZA-MORENO F, DÌEZ-GAGO M R, MÌNGUEZ-GARCÌA J, et al. Mixed adenoneuroendocrine carcinoma of the esophagus: a case report and review of the literature[J]. Niger J Surg, 2018, 24(2): 131-134. doi: 10.4103/njs.NJS_43_17
    [3]
    YAMAMOTO M, OZAWA S, KOYANAGI K, et al. Mixed adenoneuroendocrine carcinoma of the esophagogastric junction: a case report[J]. Surg Case Rep, 2018, 4(1): 56. doi: 10.1186/s40792-018-0464-x
    [4]
    KAWAZOE T, SAEKI H, EDAHIRO K, et al. A case of mixed adenoneuroendocrine carcinoma (MANEC) arising in Barrett's esophagus: literature and review[J]. Surg Case Rep, 2018, 4(1): 45. doi: 10.1186/s40792-018-0454-z
    [5]
    DULSKAS A, PILVELIS A. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): a single center case series[J]. Eur J Surg Oncol, 2020, 46(1): 105-107. doi: 10.1016/j.ejso.2019.08.002
    [6]
    中华医学会病理学分会消化疾病学组, 2020年中国胃肠胰神经内分泌肿瘤病理诊断共识专家组. 中国胃肠胰神经内分泌肿瘤病理诊断共识(2020版)[J]. 中华病理学杂志, 2021, 50(1): 14-20.
    [7]
    WHO Classification of Tumours Editorial Board. WHO classificaion of tumours of digestive system[M]. Lyon: IARC Press, 2019: 211-220.
    [8]
    SORBYE H, WELIN S, LANGER S W, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study[J]. Ann Oncol, 2013, 24(1): 152-160. doi: 10.1093/annonc/mds276
    [9]
    TANG L H, UNTCH B R, REIDY D L, et al. Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas[J]. Clin Cancer Res, 2016, 22(4): 1011-1017. doi: 10.1158/1078-0432.CCR-15-0548
    [10]
    SHI H Y, QI C H, MENG L J, et al. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis?A SEER database analysis of 12878 cases[J]. Ther Adv Endocrinol Metab, 2020, 11: 1-10. http://www.researchgate.net/publication/342731234_Do_neuroendocrine_carcinomas_and_mixed_neuroendocrine-non-neuroendocrine_neoplasm_of_the_gastrointestinal_tract_have_the_same_prognosis_A_SEER_database_analysis_of_12878_cases
    [11]
    LA ROSA S, INZANI F, VANOLI A, et al. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms[J]. Hum Pathol, 2011, 42(10): 1373-1384 doi: 10.1016/j.humpath.2011.01.018
  • Related Articles

    [1]ZHOU Xiaoping, QIAO Jimin, LI Kai, WANG Zhimei. Efficacy of selective ulnar artery continuous circulatory compression in reducing radial artery occlusion in elderly patients with coronary heart disease undergoing coronary intervention[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 122-125, 130. DOI: 10.7619/jcmp.20233706
    [2]CONG Linqiang. Effect of plasma microRNA-34a level on degree of coronary artery disease in coronary atherosclerotic heart disease patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 102-106. DOI: 10.7619/jcmp.20215098
    [3]SHEN Qin, ZHANG Xiao, WU Ting, CHEN Liang. Clinical value of calcification scores of coronary artery CT angiography in evaluating coronary artery lesions and prognosis in patients with chronic angina pectoris[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 1-4, 8. DOI: 10.7619/jcmp.20213903
    [4]ZHANG Qiu, SUN Ling, WANG Qingjie, JI Yuan, JIANG Jianguang. Value of growth differentiation factor-15 in predicting risk of acute kidney injury in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 15-18. DOI: 10.7619/jcmp.202016004
    [5]YANG Fubao, LIU Jiaojiao. Value of echocardiogram and electrocardiogram in diagnosis of Kawasaki disease patients with coronary artery lesions[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 47-50. DOI: 10.7619/jcmp.202006013
    [6]WANG Jingwu, AI Fengying, WANG Dasheng, WU You, SU Yanjie, YANG Xinquan, WANG Daxin. Relationship between plasma TSP-1 and degree of coronary artery stenosis[J]. Journal of Clinical Medicine in Practice, 2018, (9): 6-10. DOI: 10.7619/jcmp.201809002
    [7]GENG Jiafeng. Correlation between N-terminal brain natriuretic peptide, lipoprotein (a) and coronary artery disease in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2016, (15): 14-16,20. DOI: 10.7619/jcmp.201615004
    [8]ZHUO Bo. Application effect of specialized nursing in coronary artery stent implantation[J]. Journal of Clinical Medicine in Practice, 2015, (4): 4-6. DOI: 10.7619/jcmp.201504002
    [9]ZHAO Yanzhong. Correlation between success rate of 64 row CT coronary artery examinationand anxiety and depression statuses of patients[J]. Journal of Clinical Medicine in Practice, 2014, (1): 116-118. DOI: 10.7619/jcmp.201401039
    [10]LI Xiaomei. Clinical values of HCY and hs-CRP in assessment of coronary artery changesin patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2014, (1): 20-22. DOI: 10.7619/jcmp.201401006
  • Cited by

    Periodical cited type(13)

    1. 付中英,杨燕玲,苏月华,于晗澍,李曼,朱凤芹,常红. 过敏性紫癫患儿外周血单个核细胞中ASC mRNA和NLRP3 mRNA表达水平及其与并发肾炎的关系. 中国妇幼健康研究. 2024(11): 20-31 .
    2. 刘阳,郝佳,卑雪,赵志佳,李阳. 过敏性紫癜患儿幽门螺杆菌感染及其对补体系统及炎症指标的影响. 中华医院感染学杂志. 2023(01): 138-141 .
    3. 郭爱玲. 学龄前期HP阳性儿童的免疫功能及生长发育的特点. 哈尔滨医药. 2023(01): 33-35 .
    4. 潘馨,刘佳奕,王艳,童敏,严方利,孙香娟. 幽门螺杆菌感染与儿童过敏性紫癜相关性的Meta分析. 医学信息. 2023(02): 92-98 .
    5. 黄丽琴,江秀华. 微生态制剂结合抗Hp三联方案治疗Hp阳性腹型AP患儿的效果. 数理医药学杂志. 2022(06): 893-895 .
    6. 孙文,黄雅玲,高健. 腹型过敏性紫癜患儿幽门螺杆菌感染与消化道出血的关系及相关因素探讨. 现代消化及介入诊疗. 2022(03): 355-358 .
    7. 王彩芳,么鑫,蔡花,张菂,黄翠影,梁晓亮,陈瑞珊,海冬. 肺炎链球菌、肺炎支原体、柯萨奇病毒及EB病毒感染与儿童过敏性紫癜肾炎的相关性研究. 临床和实验医学杂志. 2022(19): 2099-2103 .
    8. 刘力铭,张颖,赵子年,杨金玉,焦丽华,刘建丽,回广飞. 过敏性紫癜患儿呼吸道病毒感染特异性免疫球蛋白M检测及血清炎性因子变化. 临床军医杂志. 2021(07): 768-769 .
    9. 王杨. 过敏性紫癜患儿血清中Cys C、TM与T淋巴细胞亚群的关系及易感因素分析. 中国医学创新. 2021(21): 10-14 .
    10. 王士杰,胡方起,和平,余必信,邓芳. 黄芪颗粒联合氢化可的松琥珀酸钠治疗过敏性紫癜临床疗效与安全性探究. 中华中医药学刊. 2021(09): 169-172 .
    11. 王婧,韩磊,张震,夏毓,姜烜星,汤兴萍. 儿童过敏性紫癜感染幽门螺杆菌的危险因素分析与治疗研究. 系统医学. 2021(16): 31-34 .
    12. 李丹,张波,秦帅,刘宇. 微生态制剂结合抗幽门螺杆菌三联方案治疗儿童幽门螺杆菌阳性腹型过敏性紫癜的疗效分析. 中国现代医学杂志. 2021(19): 44-48 .
    13. 郭志伟. 探究儿童过敏性紫癜临床用药的治疗效果. 中国继续医学教育. 2021(30): 156-159 .

    Other cited types(1)

Catalog

    Article views (454) PDF downloads (27) Cited by(14)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return